LoginRegister
    Jubilant Cadista recalls 1.58 lakh bottles of erosive esophagitis tabletsJubilant Cadista recalls 1.58 lakh bottles of erosive esophagitis tablets
    FDA snubs Novartis bid to repurpose inflammation drug canakinumab for heart attacksFDA snubs Novartis bid to repurpose inflammation drug canakinumab for heart attacks
    Takeda gets Japans approval for $62 billion Shire purchaseTakeda gets Japan's approval for $62 billion Shire purchase
    Shires drug Takhzyro for rare swelling disorder wins European panel green lightShire's drug Takhzyro for rare swelling disorder wins European panel green light
    Dengue vaccine should be approved: European Medicines AgencyDengue vaccine should be approved: European Medicines Agency
    Sanofi drug Dupixent wins USFDA approval to treat asthmaSanofi drug Dupixent wins USFDA approval to treat asthma
    Maryland asks Supreme Court to uphold law on drug pricingMaryland asks Supreme Court to uphold law on drug pricing
    Zydus Cadila gets USFDA nod for generic gout attacks drug- ColchicineZydus Cadila gets USFDA nod for generic gout attacks drug- Colchicine
    Novartis to buy cancer drugmaker Endocyte for $2.1 Billion in cashNovartis to buy cancer drugmaker Endocyte for $2.1 Billion in cash
    Trivitron launches 4 novel Newborn Screening panels, Check out detailsTrivitron launches 4 novel Newborn Screening panels, Check out details
    Zydus Cadila gets USFDA nod to market Clobetasol Propionate cream for skin treatmentZydus Cadila gets USFDA nod to market Clobetasol Propionate cream for skin treatment
    Samsung launches third rival to AbbVies Humira drug in EUSamsung launches third rival to AbbVie's Humira drug in EU
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X